Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
3.
Brain Dev ; 45(2): 134-139, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36220738

ABSTRACT

Perinatal lethal Gaucher disease is a very rare variant of type 2 Gaucher disease that occurs in the neonatal period and leads to death in early infancy. The disease is characterized by hydrops fetalis or a collodion baby phenotype accompanied with progressive neurological manifestations, hepatosplenomegaly, thrombocytopenia, anemia, and failure to thrive. We report a case of perinatal lethal Gaucher disease treated with enzyme replacement therapy (ERT) who survived for 9 months and present a literature review of perinatal lethal Gaucher disease cases. The prognosis of perinatal lethal Gaucher disease is poor, and ERT is only effective in visceral manifestation. Therefore, palliative care should be recognized as a treatment option, and ERT employment needs to be discussed in this context.


Subject(s)
Gaucher Disease , Humans , Female , Pregnancy , Gaucher Disease/complications , Glucosylceramidase/genetics , Enzyme Replacement Therapy , Hydrops Fetalis
4.
Cureus ; 14(11): e31138, 2022 Nov.
Article in English | MEDLINE | ID: mdl-36479407

ABSTRACT

Bacterial meningitis in infants is a life-threatening illness that survives significant neurological sequelae that remain in survivors. The current diagnostic gold standard for meningitis is bacterial isolation from culture or molecular diagnostics in the cerebrospinal fluid. The decision for antibiotics therapy before bacterial detection is made on microscopic and biochemical findings in the cerebrospinal fluid, however, some patient shows no microscopic finding and pleocytosis at the initial cerebrospinal fluid analysis. Herein, we report a case of late-onset group B Streptococcus serotype Ib meningitis that could be introduced with timelier antibiotic therapy even in the absence of pleocytosis without the detection of bacteria on smear at the initial CSF analysis.

5.
Pediatr Infect Dis J ; 41(10): e440-e442, 2022 10 01.
Article in English | MEDLINE | ID: mdl-35895886

ABSTRACT

Edwardsiella tarda , a Gram-negative bacterium classified into the genus Enterobacteriaceae, causes self-limited gastroenteritis. Here, we report a case of E. tarda gastroenteritis in a previously healthy 12-year-old boy in whom inflammatory bowel disease was precluded by endoscopy and tissue biopsy due to 3-month history of diarrhea, abdominal pain and weight loss.


Subject(s)
Enterobacteriaceae Infections , Gastroenteritis , Child , Diarrhea/complications , Edwardsiella tarda , Enterobacteriaceae , Enterobacteriaceae Infections/complications , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/microbiology , Gastroenteritis/microbiology , Humans , Male
6.
Paediatr Child Health ; 27(4): 193-194, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35859675
8.
Biol Pharm Bull ; 28(10): 1886-91, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16204940

ABSTRACT

The effects of a liquid nutritive and tonic drug (NTD) selected from a modification of the "Kai-xin-shou-yu-shen-qi-wan" prescription, on scopolamine-induced amnesia in mice were investigated using the passive avoidance and water-maze tasks. A popular NTD in Japan that contains 17 crude (natural) drug extracts together with synthetic drugs such as taurine, caffeine, various vitamins and ethanol, and the natural drug extracts is based on a prescription of "Kampo" origin in Chinese medicine. Scopolamine (0.4 mg/kg, i.p.) reduces the step-through latency of the passive avoidance test and fear reaction behavior at 24 and 48 h after treatment. A single oral administration of the NTD (10 ml/kg) increased the step-through latency and the fear reaction behavior score in scopolamine-treated mice. Administration of the natural drug extracts found in the NTD tended to extend the step-through latency in the retention test at 48 h, but not 24 h after the initial scopolamine trial. However, administration of the synthetic drugs found in the NTD did not improve either the step-through latency or the behavioral score. The NTD and the natural drug extracts also improved the scopolamine-induced spatial memory impairment as assessed using the Morris water-maze test. In contrast, the synthetic drugs did not affect the escape latencies. Both NTD and the synthetic drugs increased the locomotor activity in scopolamine-treated mice, whereas the natural drug extracts did not. These results suggest that NTD improves scopolamine-induced amnesia, and that this action is attributable to the natural drug extracts in the NTD.


Subject(s)
Beverages , Memory Disorders/therapy , Scopolamine/toxicity , Animals , Male , Maze Learning , Memory Disorders/chemically induced , Mice , Mice, Inbred ICR , Motor Activity , Nutritive Value
SELECTION OF CITATIONS
SEARCH DETAIL
...